𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Challenge of Pathway and Environment-mediated Drug Resistance

✍ Scribed by Edward A. Sausville

Book ID
110319209
Publisher
Springer
Year
2001
Tongue
English
Weight
62 KB
Volume
20
Category
Article
ISSN
0167-7659

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reversal of breast cancer resistance pro
Reversal of breast cancer resistance protein–mediated drug resistance by tryprostatin A
✍ Holger Woehlecke; Hiroyuki Osada; Andreas Herrmann; Hermann Lage πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 391 KB πŸ‘ 1 views

## Abstract MDR in human cancers is one of the major causes of failure of chemotherapy. A member of the superfamily of ABC transporters, BCRP, was demonstrated to confer an atypical MDR phenotype to tumor cells. To overcome the BCRP‐mediated drug resistance, the fungal secondary metabolite TPS‐A, a

Verapamil suppresses the emergence of P-
Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance
✍ Bernard W. Futscher; Nils E. Foley; Mary C. Gleason-Guzman; Paul S. Meltzer; Dan πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 830 KB

Selection protocols were designed to determine whether non-cytotoxic chemomodifiers can influence the evolution of the drug-resistant phenotype. To this end, the human multiple myeloma cell line RPMl8226 (8226/S) was selected with either doxorubicin, verapamil or doxorubicin plus verapamil. Using th

The use of nanoparticle-mediated targete
The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
✍ Yogesh B. Patil; Suresh K. Swaminathan; Tanmoy Sadhukha; Linan Ma; Jayanth Panya πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 805 KB

Overexpression of drug efflux transporters such as P-glycoprotein (P-gp) enables cancer cells to develop resistance to multiple anticancer drugs. Functional inhibitors of P-gp have shown promising efficacy in early clinical trials, but their long-term safety is yet to be established. A novel approac

APDR5 -independent pathway of multi-drug
APDR5 -independent pathway of multi-drug resistance regulated by theSIN4 gene product
✍ Fleckenstein, Anne; Shallom, Joshua; Golin, John πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 146 KB

The SIN4 locus encodes a global transcriptional regulator of various yeast genes. In this report, we demonstrate that loss of function mutations in SIN4 create a multi-drug hypersensitive phenotype that is independent of PDR5 mediated resistance. Thus, double sin4, pdr5 mutants are more sensitive th